Arkolith/Insider Trading/PBYI/Form 4

Miller Michael Patrick

DirectorPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Nov 9, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$71K
Net Open-Market Flow
-$71K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2023Sell(S)25K$2.83$71K43K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-031275) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML